Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;22(5):666-673.
doi: 10.1007/s13365-016-0443-6. Epub 2016 May 2.

Cystatin B and HIV regulate the STAT-1 signaling circuit in HIV-infected and INF-β-treated human macrophages

Affiliations

Cystatin B and HIV regulate the STAT-1 signaling circuit in HIV-infected and INF-β-treated human macrophages

L E Rivera et al. J Neurovirol. 2016 Oct.

Abstract

Cystatin B is a cysteine protease inhibitor that induces HIV replication in monocyte-derived macrophages (MDM). This protein interacts with signal transducer and activator of transcription (STAT-1) factor and inhibits the interferon (IFN-β) response in Vero cells by preventing STAT-1 translocation to the nucleus. Cystatin B also decreases the levels of tyrosine-phosphorylated STAT-1 (STAT-1PY). However, the mechanisms of cystatin B regulation on STAT-1 phosphorylation in MDM are unknown. We hypothesized that cystatin B inhibits IFN-β antiviral responses and induces HIV replication in macrophage reservoirs through the inhibition of STAT-1 phosphorylation. Macrophages were transfected with cystatin B siRNA prior to interferon-β treatment or infected with HIV-ADA to determine the effect of cystatin B modulation in STAT-1 localization and activation using immunofluorescence and proximity ligation assays. Cystatin B decreased STAT-1PY and its transportation to the nucleus, while HIV infection retained unphosphorylated STAT (USTAT-1) in the nucleus avoiding its exit to the cytoplasm for eventual phosphorylation. In IFN-β-treated MDM, cystatin B inhibited the nuclear translocation of both, USTAT-1 and STAT-1PY. These results demonstrate that cystatin B interferes with the STAT-1 signaling and IFN-β-antiviral responses perpetuating HIV in macrophage reservoirs.

Keywords: Cystatin B; HIV; IFN-β; Macrophages; STAT-1.

PubMed Disclaimer

Conflict of interest statement

LMM has a patent application approved for cystatin B, related to this manuscript. Pat No. 8,143,231.

Figures

Fig. 1
Fig. 1. Cystatin B inhibits the nuclear translocation of USTAT-1 in IFN-β treated MDM
Uninfected MDM induced by IFN-β were assayed by immunofluorescence for cystatin B (green) and USTAT-1 (red). Blue fluorescent DAPI was used as nuclear stain. MDM expressing cystatin B before (1–3) and after IFN-β treatment (7–9), showed a cytoplasmic localization of STAT-1. In absence of cystatin B, USTAT-1 was retained in the cytoplasm of untreated MDM (4–6), but USTAT-1 was completely translocated to the nucleus in IFN-β treated MDM after silencing of cystatin B (10–12). Non-targeting siRNA was used as a control for the cystatin B silencing procedure (1–3 and 7–9). Confocal images were obtained on a Zeiss confocal microscope Axiovert 200M with a LSM 510, 40x. The results are representative of experiments performed using three different donors.
Fig. 2
Fig. 2. Cystatin B inhibits the nuclear translocation of USTAT-1 in HIV-infected MDM
Nuclear translocation of STAT-1 was observed in HIV-1 infected MDM treated with cystatin B siRNA. At 12DPI, HIV-infected MDM were assayed by immunofluorescence for cystatin B (green) and USTAT-1 (red). Blue fluorescent DAPI was used as nuclear stain. Non-targeting siRNA was used as siRNA control. Cystatin B was silenced in MDM cultures using siRNA. Uninfected MDM expressing cystatin B showed a predominantly cytoplasmic localization of USTAT-1 (1–3). After cystatin B gene silencing, STAT-1 was retained in the cytoplasm of uninfected MDM (4–6) as well as in HIV infected MDM treated with non- targeting siRNA (7–9). At 12 DPI, USTAT-1 was totally translocated to the nucleus in HIV-infected MDM after cystatin B gene silencing (10–12). Images were obtained on a Nikon Eclipse E400 fluorescence microscope with a SPOT Insight QE camera and SPOT 5.1, 40x. These results are representative of two independent experiments performed using two different donors.
Fig. 3
Fig. 3. The role of cystatin B in STAT-1 Activation in MDM is mediated by STAT-1PY
The effect of cystatin B modulation in STAT-1PY were examined in induced MDM. (A) Cystatin B inhibits the STAT-1PY nuclear translocation in IFN-B-induced MDM. Uninfected MDM induced by IFN-β were assayed with PLA in situ. Non-targeting siRNA and unstimulated MDM were used as controls. Both, unstimulated and IFN-β treated MDM showed a cytoplasmic localization of STAT1-PY. In IFN-β treated MDM, STAT-1PY is translocated to the nucleus after silencing of cystatin B. (B) Cystatin B inhibits STAT-1PY in HIV infected MDM. (1) In situ PLA was used to determine the STAT1PY in HIV infected MDM treated with cystatin B siRNA. siRNA treatment against cystatin B increased the STAT-1 tyrosine phosphorylation in HIV infected MDM. (2) An unpaired two-tailed Student’s t-test was used to compare the PLA signals of Tyrosine-phosphorylated-STAT1 in uninfected and HIV-infected MDM treated with or without anti-cystatin B siRNA. (C) HIVp24 antigen levels from MDM supernatants of two donors at 3,6 and 12 days post-infection shows a productive infection. (D) Experimental controls included: (1) Biological Positive control consisting of uninfected MDM stained for cystatin B/cathepsin B interacting proteins, (2) Biological Negative control consisting of HIV-infected MDM that lost cystatin B/cathepsin B interaction, (3) A Technical control included the absence of the primary antibody and (4) STAT-1PY in IFN-β-treated MDM. Images were obtained on a Nikon Eclipse E400 fluorescence microscope with a SPOT Insight QE camera and SPOT 5.1, 40x. These results are representative of two independent experiments using two different donors.
Fig. 3
Fig. 3. The role of cystatin B in STAT-1 Activation in MDM is mediated by STAT-1PY
The effect of cystatin B modulation in STAT-1PY were examined in induced MDM. (A) Cystatin B inhibits the STAT-1PY nuclear translocation in IFN-B-induced MDM. Uninfected MDM induced by IFN-β were assayed with PLA in situ. Non-targeting siRNA and unstimulated MDM were used as controls. Both, unstimulated and IFN-β treated MDM showed a cytoplasmic localization of STAT1-PY. In IFN-β treated MDM, STAT-1PY is translocated to the nucleus after silencing of cystatin B. (B) Cystatin B inhibits STAT-1PY in HIV infected MDM. (1) In situ PLA was used to determine the STAT1PY in HIV infected MDM treated with cystatin B siRNA. siRNA treatment against cystatin B increased the STAT-1 tyrosine phosphorylation in HIV infected MDM. (2) An unpaired two-tailed Student’s t-test was used to compare the PLA signals of Tyrosine-phosphorylated-STAT1 in uninfected and HIV-infected MDM treated with or without anti-cystatin B siRNA. (C) HIVp24 antigen levels from MDM supernatants of two donors at 3,6 and 12 days post-infection shows a productive infection. (D) Experimental controls included: (1) Biological Positive control consisting of uninfected MDM stained for cystatin B/cathepsin B interacting proteins, (2) Biological Negative control consisting of HIV-infected MDM that lost cystatin B/cathepsin B interaction, (3) A Technical control included the absence of the primary antibody and (4) STAT-1PY in IFN-β-treated MDM. Images were obtained on a Nikon Eclipse E400 fluorescence microscope with a SPOT Insight QE camera and SPOT 5.1, 40x. These results are representative of two independent experiments using two different donors.

Similar articles

Cited by

References

    1. Aboud L, Ball TB, Tjernlund A, Burgener A. The role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against HIV. Am J Reprod Immunol. 2014;71:12–23. - PubMed
    1. Burgener a, Rahman S, Ahmad R, et al. Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. J Proteome Res. 2011;10:5139–5149. - PubMed
    1. Burdo TH, Walker J, Williams KC. Macrophage Polarization in AIDS: Dynamic Interface between Anti-Viral and Anti-Inflammatory Macrophages during Acute and Chronic Infection. 2015 - PMC - PubMed
    1. Cassetta L, Kajaste-Rudnitski A, Coradin T, et al. M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication. Aids. 2013;27:1847–1856. - PubMed
    1. Cheon H, Stark GR. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci U S A. 2009;106:9373–9378. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources